Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. (Q47987190)

7 February 2018

title

Lysophosphatidylcholine induces the production of IL-1beta by human monocytes. (English)

1 reference

7 February 2018

3

Wiklund O

1 reference

7 February 2018

author name string

Liu-Wu Y

series ordinal

1

1 reference

7 February 2018

Hurt-Camejo E

series ordinal

2

1 reference

7 February 2018

publication date

1 April 1998

1 reference

7 February 2018

published in

Atherosclerosis

1 reference

7 February 2018

volume

137

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

page(s)

351-357

1 reference

7 February 2018

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Quantitation of mRNA by the polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Characterization of extracellular phospholipase A2 in rheumatoid synovial fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Expression of lipoprotein lipase mRNA and secretion in macrophages isolated from human atherosclerotic aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Differential effects of human interleukin-1 on growth of human fibroblasts and vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

Interleukin-1 activates phospholipase A2 in human synovial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900295-5

10.1016/S0021-9150(97)00295-5

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

release_mpxo5f25rffbnpqahgtfjocr2i

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mpxo5f25rffbnpqahgtfjocr2i

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9622278

1 reference

7 February 2018